The FDA has designated Conexxence and Bomyntra as interchangeable biosimilars to the reference products Prolia and Xgeva, ...

AID systems were associated with varying glycemic outcomes in type 1 diabetes, with MiniMed 780G users demonstrating best time in range.

Type 2 diabetes was associated with social and environmental factors including access to free or reduced-cost meals among children.

Peri- and postmenopause are associated with FVC declines, suggesting that menopause status may be linked to lung function trajectories.

The FDA has announced new rules for the approval of biosimilar drug products that could reduce 5- to 8-year timelines by half.

Radiofrequency renal denervation was associated with significant blood pressure reduction among individuals with chronic kidney disease.

Since Serena Williams’s endorsement of GLP-1 medicaitons, questions have risen regarding stigma and their ...

Exposure to sugar restriction during the first 1,000 days of life is associated with lower cardiovascular risks in adulthood.

Diabetes incidence was higher among postmenopausal women who reported SARS-CoV-2 infection, multiple COVID-19 symptoms, or COVID-19 hospitalization.

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

Kidney and cardiovascular outcomes were similar between liraglutide, dulaglutide, and semaglutide among patients with type 2 diabetes.

A scientific statement has been published by the American Heart Association regarding cardiac rehabilitation in women.